Dioxotriazine derivatives as a new class of P2X3 receptor antagonists: Identification of a lead and initial SAR studies.

MLA

Kai, Hiroyuki, et al. “Dioxotriazine Derivatives as a New Class of P2X3 Receptor Antagonists: Identification of a Lead and Initial SAR Studies.” Bioorganic & Medicinal Chemistry Letters, vol. 37, Apr. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bmcl.2021.127833.

APA

Kai, H., Horiguchi, T., Kameyama, T., Asahi, K., Endoh, T., Jikihara, S., Hasegawa, T., Tanaka, S., Nozu, A., Takeyama, C., Tomari, M., Takahashi, F., Tamura, N., Yagi, S., Itoh, T., & Isou, Y. (2021). Dioxotriazine derivatives as a new class of P2X3 receptor antagonists: Identification of a lead and initial SAR studies. Bioorganic & Medicinal Chemistry Letters, 37, N.PAG. https://doi.org/10.1016/j.bmcl.2021.127833

Chicago

Kai, Hiroyuki, Tohru Horiguchi, Takayuki Kameyama, Kentaro Asahi, Takeshi Endoh, Sae Jikihara, Tsuyoshi Hasegawa, et al. 2021. “Dioxotriazine Derivatives as a New Class of P2X3 Receptor Antagonists: Identification of a Lead and Initial SAR Studies.” Bioorganic & Medicinal Chemistry Letters 37 (April): N.PAG. doi:10.1016/j.bmcl.2021.127833.